000 | 01693 a2200433 4500 | ||
---|---|---|---|
005 | 20250515202528.0 | ||
264 | 0 | _c20100301 | |
008 | 201003s 0 0 eng d | ||
022 | _a1205-7541 | ||
024 | 7 |
_a10.1139/Y09-075 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZamzow, Christina R | |
245 | 0 | 0 |
_aN-methyl-D-aspartate-evoked adenosine and inosine release from neurons requires extracellular calcium. _h[electronic resource] |
260 |
_bCanadian journal of physiology and pharmacology _cOct 2009 |
||
300 |
_a850-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xphysiology |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xphysiology |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 |
_aChelating Agents _xpharmacology |
650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
650 | 0 | 4 |
_aEgtazic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aInosine _xmetabolism |
650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPurines _xpharmacology |
650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
700 | 1 | _aBose, Ratna | |
700 | 1 | _aParkinson, Fiona E | |
773 | 0 |
_tCanadian journal of physiology and pharmacology _gvol. 87 _gno. 10 _gp. 850-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1139/Y09-075 _zAvailable from publisher's website |
999 |
_c19431223 _d19431223 |